Peripheral neuropathy, characterized by numbness or paresthesia of an extremity, has been reported in patients treated with systemic metronidazole. peripheral neuropathy has been reported with the post approval use of topical metronidazole.
The role of metronidazole dosing in peripheral neuropathy is not clearly defined. The objective of this review is to evaluate the literature on metronidazole-associated peripheral neuropathy and determine the relevance in clinical practice.
use of metronidazole and peripheral neuropathy, which can be irreversible and even fatal. Peripheral neuropathy is characterised by symptoms
The risk of meningitis typically goes away after treatment with metronidazole is stopped. Peripheral neuropathy: Peripheral neuropathy is caused by damage
(amiodarone), and antibiotics (metronidazole). The Foundation for Peripheral Neuropathy has a full list of medications that may cause peripheral neuropathy.
use of metronidazole and peripheral neuropathy, which can be irreversible and even fatal. Peripheral neuropathy is characterised by symptoms
Dosage is given in terms of metronidazole or metronidazole equivalent. peripheral neuropathy. Metronidazole reduces the clearance of 5-fluorouracil
Peripheral neuropathy from use of linezolid and metronidazole in a pediatric patient
Metronidazole. Both Nitrofurantoin and Metronidazole can increase the risk of peripheral neuropathy.
Comments